Member Login
  1. Stocks
    2. /
  2. AstraZeneca PLC (LSE: AZN)
    3. /

LSE:AZN (AstraZeneca PLC)

About AZN

AstraZeneca is a biopharmaceutical business that focuses on the discovery, development and commercialisation of prescription medicines, primarily for the treatment of diseases in three main therapy areas - Respiratory, Inflammation and Autoimmunity (RIA), Cardiovascular and Metabolic Disease (CVMD) and Oncology – as well as in Infection and Neuroscience.
Financial Market Data copyright © 2024 QuoteMedia. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges). RT=Real-Time, EOD=End of Day, PD=Previous Day. Market Data powered by QuoteMedia. Terms of Use.

    • AstraZeneca PLC (LSE: AZN) Latest News

    Syringe and vial on blue background
    Investing Articles

    AstraZeneca (LON:AZN) makes progress in the fight against liver cancer

    | Zaven Boyrazian, MSc

    The AstraZeneca (LON:AZN) share price idles despite the firm reporting positive results from its liver cancer clinical trials.

    Read more »

    Investing Articles

    These 2 FTSE 100 stocks are beaten down bargains in my opinion!

    | Jabran Khan

    This Fool identifies two FTSE 100 picks he believes are beaten down stocks that could be potential bargains with upside…

    Read more »

    Investing Articles

    Why I’d buy AstraZeneca shares today

    | Alexander Fazel

    AstraZeneca shares have rallied since the vaccine rollout. As we move into a post-pandemic world, I discuss why AstraZeneca piques…

    Read more »

    Investing Articles

    3 FTSE 100 stocks to buy for the long term

    | Manika Premsingh

    These FTSE 100 stocks are among the biggest gainers today, but this Fool reckons that their long-term prospects are good…

    Read more »

    Investing Articles

    2 UK shares to buy now for growth

    | Christopher Ruane

    From his list of top UK shares to buy now for his portfolio, our writer considers two firms whose growth…

    Read more »

    Investing Articles

    AstraZeneca (AZN) shares gain on acquisition news

    | Alan Oscroft

    AstraZeneca (LON: AZN) expands its presence in rare disease development with a further acquisition, sending its shares higher.

    Read more »

    Syringe and vial on blue background
    Investing Articles

    The Oxford Biomedica share price has doubled since signing its Covid-19 vaccine deal. Can the momentum continue?

    | Megan Boxall

    Oxford Biomedica’s share price is soaring. But is this simply the hype of its Covid-19 vaccine deal? Megan Boxall examines…

    Read more »

    Investing Articles

    2 FTSE 100 stocks to buy in a market crash

    | Charlie Keough

    As the FTSE 100 continues to fall, Charlie Keough looks at two stocks he would add to his portfolio should…

    Read more »

    Investing Articles

    Why is the AstraZeneca (LON: AZN) share price climbing?

    | Alan Oscroft

    The AstraZeneca share price (LON: AZN) had started to slip back a bit. But a big jump on Monday has…

    Read more »

    Investing Articles

    FTSE 100: 2 stocks to buy in a market slump

    | Suraj Radhakrishnan

    With fears of a market crash, I think buying the dip is the way to go. These two FTSE 100…

    Read more »

    Investing Articles

    2 of the best FTSE 100 stocks to buy today

    | Manika Premsingh

    The FTSE 100 index is in the red today, but not all stocks are doing badly. These two, for instance,…

    Read more »

    Investing Articles

    The AstraZeneca (AZN) share price is soaring: here’s what I’d do now

    | Alan Oscroft

    Growing drugs development success has helped lift the AstraZeneca (LON: AZN) share price, but would I buy now? For me,…

    Read more »